An Evaluation of SER120 Nasal Spray in Patients with Nocturia - Results of the Pooled Analyses of 2 Phase III Randomized, Double-Blind, Placebo Controlled Studies

Research Type

Clinical

Abstract Category

Nocturia

Links
	Abstract 234
	Rapid Communications in Urology Scientific Podium Express Session 13
	Wednesday 14th September 2016
	16:57 - 17:00
	Hall D5
	Clinical Trial Nocturia Quality of Life (QoL) Voiding Dysfunction
	1. University of Pennsylvania, 2. Vanderbilt University, 3. Serenity Pharmaceuticals, 4. Allergan plc
Presenter
A Alan Wein University of Pennsylvania
Abstract PDF Edit Abstract Abstract Centre